Overview: Evolving concepts of management of febrile neutropenia in children with cancer

Medical and Pediatric Oncology

Volumn 39, Issue 2, 2002, Pages 77-85

  Orudjev, Elmar ^a   Lange, Beverly J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Childhood cancer; Febrile neutropenia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; CANCER RISK; CHILDHOOD CANCER; COMORBIDITY; FEBRILE NEUTROPENIA; FEVER; HOSPITAL; HOSPITAL PATIENT; HUMAN; INFECTION RISK; MEDLINE; NEUTROPENIA; OUTPATIENT; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; ALGORITHM; BACTERIAL INFECTION; CHEMICALLY INDUCED DISORDER; CHILD; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; LEUKOCYTE COUNT; MICROBIOLOGY; MONOCYTE; NEOPLASM; NEUTROPHIL; PROSPECTIVE STUDY; RISK ASSESSMENT;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; FEVER; HUMANS; LEUKOCYTE COUNT; MONOCYTES; NEOPLASMS; NEUTROPENIA; NEUTROPHILS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 0036675666     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10073     Document Type: Review

References (51)

1. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer
2. Approaching the controversies in antibacterial management of cancer patients
3. Controversies in the management of febrile neutropenic cancer patients
4. Early hospital discharge of children with cancer treated for fever and neutropenia: Identification and management of the low-risk patients
5. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: Implications for discontinuation of antibiotics and early discharge from the hospital
6. Risk assessment in cancer patients with fever and neutropoenia: A prospective, two center validation of predication rule
7. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: A pilot study of 30 patients based on validated prediction rule
8. Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition
9. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complcations of sepsis
10. Predicting the risk of bacteremia in children with fever and neutropenia
11. Randomized placebo-controlled trial of oral antibiotics in pediatric oncology patients at low-risk with fever and neutropenia
12. Approach to treatment of the febrile cancer patient with low-risk neutropenia
13. The medical course of cancer patients with fever and neutropenia
14. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia
15. Ceftriaxone alone or in combination with Teicoplanin in the management of febrile episodes in neutropenic children and adolescents with cancer on an outpatient base
16. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
17. Self-administered antibiotic therapy for chemotherapy-induced, low risk febrile neutropenia in patients with nonhematologic neoplasms
18. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia
19. Economic and resourse utilization analysis of outpatient management of fever and neutropenia in low risk pediatric patients with cancer
20. Oral versus intravenous empirical antimicrobial therapy for fever and neutropenia in patients with granulocytopenia who are receiving cancer therapy
21. A double-blind comparison of empiricl oran and intravenous antibiotic therpay for low-risk patients with neutropenia during cancer chemotherapy
22. Feasibility of oral Ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer
23. Cetriaxone in outpatient tretament of cancer patients with fever and neutropenia
24. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial
25. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
26. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from EORTC studies
27. Which children with fever and neutropenia can be safely treated as outpatients?
28. "Low-risk" prediction rule for pediataric oncology patients presenting with fever and neutropenia
29. Oral administration of cefixime to lower risk febrile neutropenic children with cancer
30. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia
31. Outpatient treatment of fever and neutropenia in low risk pediatric cancer patients
32. Infection risk factors in febrile, neutropenic children and adolescents
33. Predictors of bacteremia in febrile neutropenic children with cancer
34. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: A report from the Children's Cancer Group study CCG-2891
35. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10)
36. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation and aggressive chemotherapy in children with AML in remission: A report from the Children's Cancer Group
37. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever
38. Trends in infection morbidity in a pediatric oncology ward, 1986-1995
39. Cessation of antibiotics regardless of ANC is safe in children with febrile neutropenia
40. Early hospital discharge of children with fever and neutropenia: A prospective study
41. Discontinuation of antimicrobial therapy for febrile, neutropenic children with cancer: A prospective study
42. Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer
43. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics
44. Early discharge of low-risk febrile neutropenic childlren and adolescents with cancer
45. Outpatient antimicrobial protocol for febrile neutropenia: A nonrandomized prospective trial using ceftriaxone, amikacin and oral adjuvant agents
46. Ambulatory treatment with ceftriaxone in febrile neutropenic children
47. Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients
48. Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: A literature review
49. Management of fever in granulocytopenic children with cancer
50. Outpatient management of the febrile neutropenic child with cancer
51. Fever and neutropenia - How to use a new treatment strategy